| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CD19 molecule | 0.430 | 0.885 | 0.90 |
|
group | 0.100 | None | 1.000 | 39 | 0 | 2008 | 2019 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
group | 0.100 | None | 1.000 | 31 | 0 | 1998 | 2019 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
group | 0.100 | None | 1.000 | 24 | 0 | 1993 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
group | 0.100 | None | 1.000 | 24 | 0 | 2006 | 2019 | ||||||||
|
nucleoporin 98 and 96 precursor | 0.532 | 0.577 | 1.00 |
|
group | 0.100 | None | 0.952 | 21 | 0 | 2001 | 2019 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
group | 0.100 | None | 1.000 | 18 | 0 | 1997 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
group | 0.100 | None | 1.000 | 17 | 0 | 2006 | 2020 | ||||||||
|
DNA methyltransferase 3 alpha | 0.445 | 0.846 | 7.4E-39 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 2013 | 2018 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 2006 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 1995 | 2007 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 1988 | 2018 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 2017 | 2020 | ||||||||
|
Bruton tyrosine kinase | 0.464 | 0.808 | 1.00 |
|
group | 0.100 | None | 1.000 | 14 | 0 | 2014 | 2020 | ||||||||
|
colony stimulating factor 3 | 0.377 | 0.885 | 0.38 |
|
group | 0.100 | None | 0.929 | 14 | 0 | 1999 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
group | 0.100 | None | 1.000 | 14 | 0 | 2006 | 2019 | ||||||||
|
fms related receptor tyrosine kinase 3 | 0.462 | 0.654 | 0.61 |
|
group | 0.100 | None | 1.000 | 13 | 1 | 1997 | 2019 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
group | 0.100 | None | 1.000 | 13 | 4 | 2004 | 2017 | ||||||||
|
CD38 molecule | 0.407 | 0.885 | 2.3E-06 |
|
group | 0.100 | None | 0.923 | 13 | 0 | 1997 | 2019 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
group | 0.100 | None | 1.000 | 12 | 0 | 2012 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
group | 0.100 | None | 1.000 | 11 | 0 | 1996 | 2005 | ||||||||
|
membrane spanning 4-domains A1 | 0.411 | 0.846 | 5.1E-05 |
|
group | 0.100 | None | 1.000 | 11 | 0 | 2015 | 2020 | ||||||||
|
keratin 20 | 0.388 | 0.846 | 9.1E-11 |
|
group | 0.100 | None | 1.000 | 11 | 0 | 2001 | 2018 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.100 | None | 1.000 | 10 | 0 | 1998 | 2019 | ||||||||
|
MDS1 and EVI1 complex locus | 0.513 | 0.731 | 1.00 |
|
group | 0.100 | None | 1.000 | 10 | 0 | 1994 | 2017 | ||||||||
|
MCL1 apoptosis regulator, BCL2 family member | 0.430 | 0.808 | 0.96 |
|
group | 0.100 | None | 1.000 | 10 | 0 | 2012 | 2020 |